Vol. 6, Issue 1, Part A (2024)

Background: Type 1 Diabetes Mellitus (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells, leading to absolute insulin deficiency. The progression of T1D may be rapid or gradual, with adults often retaining some residual insulin production, as indicated by detectable or higher C-peptide levels. In contrast, diabetic ketoacidosis (DKA) is more frequently observed in youth with T1D. Effective management typically requires multiple daily insulin injections (MDI), insulin pump therapy, or automated insulin delivery systems, along with glucose monitoring and comprehensive self-management education. 
Objective: To evaluate a case report on Type 1 Diabetes Mellitus (T1D). 
Methods: The patient was initially diagnosed with T1D in October 2023, with an HbA1c of 12.80% and was placed on an insulin regimen. Upon seeking a second opinion in November 2023, insulin therapy was discontinued, and a Dietary Intervention Protocol (DIP) Diet, alongside lifestyle modifications, was initiated. The patient's progress was monitored over eight months through virtual consultations. 
Results: Over the course of eight months, the patient's HbA1c decreased from 12.80% to 6.1%, and her C-peptide levels increased from 0.94 to 1.98 ng/mL. Her blood glucose levels were maintained within normal limits without insulin, and improvements were observed in vision, energy levels, and overall health. 
Conclusion: This case highlights the potential of dietary and lifestyle interventions in managing T1D, particularly in pediatric patients. The successful reduction and cessation of insulin therapy, coupled with significant improvements in glycaemic control, suggest that integrative approaches could play a valuable role in the treatment of T1D. Further research is needed to explore the broader applicability of these findings and to develop evidence-based guidelines for incorporating such interventions into standard care practices.